Table 3.

Anti-cancer properties identified in both engineered and non-engineered MSC-Exos derived from different types of MSCs.

MSC	Properties	Cancer Type	Reference
Adipocyte (AMSC)	Increase of chemosensitivity	Breast cancer	Jia et al. [167]
	Anti-proliferative	Ovarian cancer	Reza et al. [168]
	Anti-proliferative	Bladder cancer	Liu et al. [169]
	Anti-invasive
	Anti-migration
	Increase of chemosensitivity	Hepatocellular carcinoma	Lou et al. [170]
	Anti-proliferative	Glioblastoma multiforme	Pastorakova et al. [171]
Bone marrow (BMMSC)	Anti-angiogenic	Breast cancer	Lee et al. [172] Pakravan et al. [173]
	Anti-proliferative	Acute myeloid leukemia (AML)	Zhang et al. [174]
	Increase the delivery of Paclitaxel	Pancreatic adenocarcinoma	Pascucci et al. [175]
	Increase the delivery of Paclitaxel	Breast cancer	Khalimitu et al. [176]
	Increase the delivery of Doxorubicin	Neuroblastoma	Li et al. [177]
	Anti-proliferative	Glioblastoma multiforme	Pastorakova et al. [171]
Dental pulp (DPMSC)	Anti-proliferative	Glioblastoma multiforme	Pastorakova et al. [171]
	Increase the delivery of Paclitaxel	Breast cancer	Salehi et al. [178]
	Nano-delivery through intranasal route	Glioblastoma multiforme	Altanerova et al. [179]
Human umbilical cord (hUCMSC)	Anti-proliferative Pro-apoptotic	Prostate	Takahara et al. [180]
	Enhance radiotherapy-induced death	Melanoma	Farias et al. [181]
	Pro-apoptotic	Chronic myelogenous leukemia	Liu et al. [182]
	Anti-proliferative	Glioblastoma multiforme	Pastorakova et al. [171]
	Anti-proliferative	Breast cancer	Yuan et al. [183]